NCT06263231 2025-07-29INVINCIBLE-3Intensity Therapeutics, Inc.Phase 3 Active not recruiting333 enrolled
NCT01327885 2023-06-22Phase 3 Study to Compare the Efficacy and Safety of Eribulin With Dacarbazine in Subjects With Soft Tissue SarcomaEisai Inc.Phase 3 Completed452 enrolled 11 charts